Início › Câncer de Pulmão › Kansas › Overland Park
Ensaios clínicos de Câncer de Pulmão em Overland Park, KS
11 estudos para Câncer de Pulmão estão buscando participantes em locais em Overland Park e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
RecrutandoFase 3
- Saint Luke's South Hospital, Overland Park
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
RecrutandoFase 1/2
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · a 3 mi de distância
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
RecrutandoFase 3
- University of Kansas Cancer Center-Overland Park, Overland Park
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
RecrutandoFase 3
- University of Kansas Cancer Center-Overland Park, Overland Park
Integrated Cancer Repository for Cancer Research
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- Saint Luke's Cancer Instititute - South, Overland Park
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RecrutandoFase 2
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · a 3 mi de distância
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RecrutandoFase 2/3
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · a 3 mi de distância
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RecrutandoFase 2
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · a 3 mi de distância
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
RecrutandoFase 1/2
- The University of Kansas Cancer Center, Fairway · a 3 mi de distância
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
RecrutandoEstudo observacional
- Aton Health, Leawood · a 3 mi de distância
Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC
RecrutandoEstudo observacional
- The University of Kansas Cancer Center (KUCC), Fairway · a 3 mi de distância
Ensaios de Câncer de Pulmão em outras cidades
- Houston, TX78 estudos
- Boston, MA62 estudos
- New York City, NY60 estudos
- Los Angeles, CA45 estudos
- Arlington, VA41 estudos
- Washington, DC41 estudos
- Chicago, IL41 estudos
- Baltimore, MD40 estudos
- Nashville, TN40 estudos
- St. Louis, MO39 estudos
- Columbus, OH37 estudos
- Philadelphia, PA36 estudos
Outros estudos em Overland Park
- Câncer de Pulmão de Não Pequenas Células16 estudos
- Leucemia Mieloide Aguda11 estudos
- Câncer de Mama10 estudos
- Fibrilação Atrial8 estudos
- Câncer Colorretal8 estudos
- Obesidade7 estudos
- Câncer de Pâncreas7 estudos
- Câncer de Próstata7 estudos
- Melanoma6 estudos
- Sobrepeso6 estudos
- Câncer de Ovário6 estudos
- Câncer (todos os tipos)5 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.